Axial and Appendicular Bone Mineral Density in Patients with Long-Term Deficiency or Excess of Calcitonin
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Whether calcitonin deficiency causes and calcitonin excess prevents bone loss is controversial. We therefore measured plasma calcitonin levels and bone mineral density at the radius (by single photon absorptiometry) and lumbar spine (dual photon absorptiometry) in patients with an excess or deficiency of calcitonin. We studied 21 patients who had undergone subtotal thyroidectomy 6.8 to 29 years previously and had no calcitonin secretory reserve, and 11 patients who had received a diagnosis of medullary thyroid carcinoma 6.8 to 23 years previously and had chronic hypercalcitoninemia. Bone-density values, expressed as Z-scores (i.e., as the number of standard deviations above or below the normal means adjusted for age and sex), were indistinguishable from normal in the patients who had undergone thyroidectomy (means +/- SE: radius, 0.36 +/- 0.15; spine, 0.27 +/- 0.17). In the patients with medullary thyroid cancer, radial bone-density values were normal (-0.26 +/- 0.39), but spinal density was significantly reduced (-0.75 +/- 0.17, P less than 0.01). There were no significant correlations between the duration of calcitonin excess or deficiency and the bone density at either site. Bone mineral density was not affected by whether or not thyroxine replacement therapy was given. We conclude that skeletal mass is not affected by endogenous plasma calcitonin in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Calcium metabolism and bone mineral density are unaffected in patients with medullary thyroid carcinoma who have long-term excess of endogenous calcitonin levels, or in patients who had undergone thyroidectomy and have undetectable circulating calcitonin (105, 223).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [105]
In the citing paper
“Although neither the absence nor pathologically high levels of endogenous calcitonin appear to affect bone mass, pharmacological use of calcitonin was considered a promising option for the inhibition of bone turnover, preservation of bone mass, and fracture prevention (105, 223).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [105]
Citations
Cites
Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., & Melton, L. J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110039 · Cited by 1,194
Self-citationRadioimmunoassay of human parathyroid hormone in serum
Arnaud, C. D., Tsao, H. S., & Littledike, T. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106476 · Cited by 604
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
Seeman, E., Wahner, H. W., Offord, K. P., Kumar, R., Johnson, W. J., & Riggs, B. L. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110570 · Cited by 463
Self-citationCHAMBERS, T. J., McSHEEHY, P. M. J., THOMSON, B. M., & FULLER, K. (1985) · Endocrinology · doi:10.1210/endo-116-1-234 · Cited by 422
Calcitonin: Physiology and Pathophysiology
Austin, L. A., & Heath, H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101293040505 · Cited by 420
Self-citationLong-term calcitonin therapy in postmenopausal osteoporosis
Gruber, H. E., Ivey, J. L., Baylink, D. J., Matthews, M., Nelp, W. B., Sisom, K., & Chesnut, C. H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90187-2 · Cited by 329
Speer, J. D., Robertson, W. O., & Schultz, L. R. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92365-1 · Cited by 241
The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women.
Gallagher, J. C., Riggs, B. L., Jerpbak, C. M., & Arnaud, C. D. (1980) · PubMed · Cited by 208
The Sensitivity of Isolated Osteoclasts to Morphological Transformation by Calcitonin*
CHAMBERS, T. J., & MOORE, A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-819 · Cited by 195
Effect of Hyperthyroidism and Its Treatment on Bone Mineral Content
Toh, S. H. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.5.883 · Cited by 160
Research works printed but not linked: 6
- Milhaud, 1978, Biomedicine, 29, 272
- Wahner, 1977, J Nucl Med, 18, 432
- Gallagher, 1980, J Lab Clin Med, 95, 373
- Rosenfeld, 1983, Recent Prog Horm Res, 39, 305
- Toh, 1985, Arch Intern Med, 145, 883, 10.1001/archinte.1985.00360050147025 · doi:10.1001/archinte.1985.00360050147025 · Paper page
- Kaplan, 1973, Surgery, 74, 21
Cited by
Becker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery
Kovacs, C. S. (2016) · Physiological Reviews · doi:10.1152/physrev.00027.2015 · Cited by 544
Local and Systemic Factors in the Pathogenesis of Osteoporosis
Epstein, F. H., & Raisz, L. G. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803313181305 · Cited by 493
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398
The genetic transformation of bone biology
Karsenty, G. (1999) · Genes & Development · doi:10.1101/gad.13.23.3037 · Cited by 312
Metadata
- Authors
- Hurley, D. L., Tiegs, R. D., Wahner, H. W., & Heath, H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1987-08-27
- Volume
- 317
- Issue
- 9
- Pages
- 537-541
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331137246
- Cited by
- 118
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2012: 2
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am032526-03)
- National Center for Research Resources (RR-585)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- calcitonin, bone mineral density, hypercalcitoninemia, medullary thyroid carcinoma, subtotal thyroidectomy, bone loss, lumbar spine, radius, thyroxine replacement
- MeSH terms
- Adult, Aged, Aged, 80 and over, Bone and Bones, Calcitonin, Carcinoma, Female, Humans, Lumbar Vertebrae, Middle Aged, Minerals, Radius, Thyroid Neoplasms, Thyroidectomy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Axial and Appendicular Bone Mineral Density in Patients with Long-Term Deficiency or Excess of Calcitonin. https://app.cochat.ai/papers/10.1056/nejm198708273170904
- The paper
- Hurley, D. L., Tiegs, R. D., Wahner, H. W., & Heath, H. (1987). Axial and Appendicular Bone Mineral Density in Patients with Long-Term Deficiency or Excess of Calcitonin. New England Journal of Medicine. https://doi.org/10.1056/nejm198708273170904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.